NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Houte Hans VanCFO2026-11-043,300$15.38
$50.76kSell
Houte Hans VanCFO2026-11-041,469$16.20
$23.80kSell
Christine RingCLO2026-11-036,113$25.83
$157.92kSell
Gwenn HansenCSci2026-11-021,452$1.86
$2.70kBuy
Christine RingCLO2026-11-029,527$25.74
$245.22kSell
Christine RingCLO2026-11-025,786$8.72
$50.45kBuy
Gwenn HansenCSci2026-11-021,452$26.80
$38.91kSell
Christine RingCLO2026-11-021,075$26.76
$28.77kSell
Houte Hans VanCFO2026-10-302,834$26.28
$74.47kSell
Gwenn HansenCSci2026-10-303,957$26.28
$103.99kSell

1 of 7

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures III LP3.21%3,509,348$51.69MInsider
Column Group L P1.90%2,080,607$30.65MInsider
Redmile Group LLC1.08%1,176,470$17.33MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP0.72%784,313$11.55MInsider
Arthur T. Sands0.42%458,333$6.75MInsider
Robert Tjian0.11%124,999$1.84MInsider
Gwenn Hansen0.11%123,452$1.82MInsider
Pierre Beaurang0.11%120,996$1.78MInsider
Houte Hans Van0.04%42,745$629.63kInsider
David L. Lacey0.03%33,333$491.00kInsider

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX0.10%7.76%Net SellingNet Selling
MESO0.00%19.07%Net Buying
PGEN0.04%81.66%Net SellingNet Selling
ADRX0.06%45.48%Net BuyingNet Buying
SRPT0.09%28.93%Net SellingNet Selling

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 0.10% institutional shareholders, 7.76% Nurix Therapeutics insiders, and 92.14% retail investors. Third Rock Ventures III LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 3.21% of the company. Third Rock Ventures III LP's Nurix Therapeutics shares are currently valued at $49.97M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.